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Abstract
The pathogenesis of bacteraemia after challenge with one million pneumococci of three isogenic variants was investigated.
Sequential analyses of blood samples indicated that most episodes of bacteraemia were monoclonal events providing
compelling evidence for a single bacterial cell bottleneck at the origin of invasive disease. With respect to host
determinants, results identified novel properties of splenic macrophages and a role for neutrophils in early clearance of
pneumococci. Concerning microbial factors, whole genome sequencing provided genetic evidence for the clonal origin of
the bacteraemia and identified SNPs in distinct sub-units of F0/F1 ATPase in the majority of the ex vivo isolates. When
compared to parental organisms of the inoculum, ex-vivo pneumococci with mutant alleles of the F0/F1 ATPase had
acquired the capacity to grow at low pH at the cost of the capacity to grow at high pH. Although founded by a single cell,
the genotypes of pneumococci in septicaemic mice indicate strong selective pressure for fitness, emphasising the within-
host complexity of the pathogenesis of invasive disease.
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Introduction
Streptococcus pneumoniae, one of the major human bacterial
pathogens, is also part of the normal upper respiratory tract flora,
where nasopharyngeal colonisation with one or more strains often
lasts weeks to months with seasonal peaks in late winter [1,2].
Carriage of S. pneumoniae (pneumococci) may result in disease as
the consequence of contiguous spread from the nasopharynx to
other sites in the upper or lower respiratory tract causing, for
example, otitis media or pneumonia. More rarely, there is
hematogenous dissemination of pneumococci resulting in septi-
caemia and metastatic disease such as meningitis [1,3–5]. In
experimental models of pneumococcal infection, the challenge
dose required to induce disease is dependent on the route of
infection, the genetic background of the host and the virulence of
the infecting strain [6] and may vary from a very few to millions of
organisms [7]. Following intravenous inoculation of mice with
laboratory grown pneumococci, a hallmark of experimental
bacteraemic infections is the rapid and efficient clearance of most
of the inoculated bacteria [8–10]. In non-immune rodents, major
factors mediating this clearance are splenic macrophages and
complement mediated opsonisation [11–14]. A challenge dose of
about one million virulent, encapsulated pneumococci is generally
needed to induce bacteraemia in about half of challenged animals
(the effective dose or ED50) and which is the dose generally used to
address investigations into the early events shaping an infectious
process.
Most work on the pathogenesis of infectious disease focuses on
specific virulence determinants which are generally presented as
the cause, either alone or in combination with other factors, of the
events leading to the infection of the host where the microbial
population is considered to be a uniform entity. However, several
investigations have addressed the within host population dynam-
ics, especially on the early phases of host-pathogen interactions
[15]. There are different models which address these early events
that include: (i) the model of independent action, which postulates
that at the LD50 (lethal dose for 50% for the hosts) the hosts
develop infection ‘‘following the multiplication of only one of the
inoculated bacteria, regardless of the total number of bacteria
inoculated’’ [16], (ii) the hypothesis of synergy which ‘‘postulates
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that inoculated bacteria co-operate and that fatal infections will be
initiated by more than one bacterium and that this will lead to the
predominance of several variants’’ [16], and models which
introduce time as a factor into the process and propose a two-
stage model where a birth–death phase would be responsible for
generation of the heterogeneity within the population later during
the infection [17].
Both for viral and bacterial infections it has been shown that the
effective number of infectious agents which actually start the
disease is generally many orders of magnitude below the actual
dose used for challenge [16,16,18–21]. In particular a series of
reports, generally based on experimental challenge using an
inoculum containing an approximately equal mixture of two
isogenic variants at the LD50, has shown experimentally that
systemic infections may be initiated by the multiplication of as few
as a single organism [22–27]. Models differ widely, and due to the
nature of pathogenesis of many infections, they rely on experi-
mental challenge at a site different to that investigated for disease
implying that multiple bottlenecks occur and that potentially a series
of invasive events could be enucleated [16,18–27]. We here have
investigated the host and microbial determinants that underpin the
occurrence of the single cell bottleneck in the pathogenesis of
pneumococcal septicaemia following inoculation of mice with three
isogenic variants by the intravenous route. This route has an
advantage over other experimental infection models as there are less
biological events between the initial challenge and full blown disease
so that rigorous analysis of the events is facilitated.
Results
The population of pneumococci in the blood is clonal
within hours of inoculation
CD1 mice were inoculated intravenously (i.v.) with a mixture of
pneumococci comprising approximately equal numbers of each of
three isogenic TIGR4 mutants (FP122, FP321 and FP318) with
different resistance markers (Table 1) [28]. Following inoculation,
blood samples were collected at different times and spread on
selective plates. Colony counts allowed quantitation of the
distribution of the different mutants making up the pneumococcal
population in the blood (Figure 1). Two hours after bacterial
challenge, blood samples from all mice, with one exception, grew
all three of the variants that had been included in the challenge
dose. Samples of the second group of mice, sampled one hour
thereafter, showed a mixed population of the variants: two in 6
mice, three in 17 mice and one mouse had negative blood culture
(Figure 1A). At 7 h after challenge, this pattern was distinctly
different: there were 10 positive and 2 negative blood cultures and
the numbers of bacteria were significantly reduced. At 8–9 h post-
infection, most blood cultures (25/29 mice) were negative. The
remaining 4 mice had monoclonal blood cultures in that each
grew colonies of only one mutant (Figure 1A). In the subsequent
hours of infection, bacteria were detected in the blood at high
Author Summary
Decades of research on bacterial sepsis have been devoted
to analysing the steps that lead from a local event, either
carriage or a localised infection, to systemic disease. Our
work analyses in depth the events determining systemic
infection by one of the main human pathogens, Strepto-
coccus pneumoniae. Consistent with similar findings on the
pathogenesis of bacteraemia due to other commensal
pathogens, our results show that after an intravenous
inoculum of a million pneumococci, the resulting septi-
caemia is often founded by a single bacterial cell.
Investigation into the nature of this monoclonal infection
identified strong within-host selective pressure for meta-
bolic fitness during outgrowth of the bacterial population.
Table 1. Pneumococcal strains.
Strain Background Type Comment Reference
D39 wt 2 [62]
DP1004 D39 rough Un-encapsulated, streptomycin resistant [51]
G54 wt 19F erythromycin and tetracycline resistant [50]
TIGR4 wt 4 [63]
FP122 TIGR4 4 zmpC::ermB [28,48]
FP318 TIGR4 4 zmpC::aad9 this work
FP321 TIGR4 4 zmpC::aphIII this work
FP335 D39 2 bglA::aad9 gift of Hasan Yesilkaya
FP487 FP318 4 SP1507 atpC mutant* this work
FP489 FP321 4 SP1508 atpD mutant* this work
FP490 FP321 4 SP1513 atpB mutant* this work
FP498 FP321 4 SP1508 atpD mutant* this work
FP499 DP1004 Rough SP1507 atpC mutant* this work
FP500 DP1004 Rough SP1507 atpC mutant* this work
FP503 FP321 4 SP1510 atpA mutant* this work
FP504 FP321 4 SP1510 atpA mutant* this work
FP505 FP318 4 SP1508 atpD mutant* this work
FP506 FP321 4 SP1509 atpG mutant* this work
*see Table 3 for detailed description.
doi:10.1371/journal.ppat.1004026.t001
One-Cell Bottleneck for Invasive Infection
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concentrations (up to 16106 CFU) in 17/55 (31%) mice at 24 h,
16/43 (37%) mice at 48 h and 15/24 (62%) mice at 72 h
(Figure 1B). At all these time points, most blood samples yielded
colonies of only one of the variants: 12 out of 17 blood cultures at
24 h, 12/16 at 48 h and 8/16 at 72 h. Among the 32 single-
variant blood samples each variant was more or less equally
represented as the progenitor, although owing to the smaller
challenge dose of strain FP318 in one experiment, this strain was
recovered at lower density from the blood and caused fewer single-
variant infections (Table S1). In three of twelve mice for which
three serial blood cultures were taken we observed an increase in
the number of variants. One of these mice showed evidence of
infection with 3 variants at 48 h after earlier having a monoclonal
infection and a further two mice had three variants infection at
72 h after having previously had infection with only one or two
variants respectively. Seven of the single-variant bacteraemia
isolates were checked for colony morphology and each was found
to have the opaque phenotype, in contrast to the challenge strains
(not-mouse-passaged) that yielded a mixed population of about
similar proportions of opaque and translucent colonies [29].
The bacterial counts from cultures of spleen tissue were assayed
in twelve mice at each time point (Figure S1). All mice which had
positive blood cultures showed bacterial counts also in splenic
samples. In addition, small numbers of organisms were cultured
from spleen tissue both at 24 and 48 h in two mice each which
presented with sterile blood cultures. Similarly at 72 h, bacteria
were only detected in the spleen in one mouse (Figure S1). These
data show that infectious foci can be detected in the spleens of
mice that have negative blood cultures, indicating that the spleen is
the probable site where the infection originates.
Statistical analysis shows that bacteraemia is
independently founded by a single organism
Our data indicate that the near totality of bacteria in the
challenge with three isogenic pneumococcal variants is cleared by
the immune system (predominantly by splenic macrophages; see
below) and that few bacterial cells remain viable within a defined
site of the host (i.e. the spleen). This small number of bacteria may
start to grow and re-invade the host giving rise to bacteraemia. In
our experimental infection most of the mice challenged were not
bacteraemic and, of those becoming bacteraemic, most were
infected by a single bacterial variant. In addition, we detected in
some mice an increase in variants within blood cultures over time.
These data indicate that over time more than one invasion event
may occur. Theoretically bacteraemia may be generated in two
ways: (i) by a single bacterium establishing a population in the
blood in a single invasion event or several bacteria each
independently establishing a population in distinct invasion events
(independent action); (ii) by a defined number (more than one) of
bacteria acting together to invade once or several times (co-
operative synergism) [22]. We hypothesise that the former
explanation pretains.
To statistically evaluate the number of bacteria involved in
founding the blood population in each invasion event, we
construct a model that assumes that bacteria invade and establish
a population in the blood at random (Supplementary text) [23]. In
this model, the number of invasion events in each mouse is
assumed to follow a Poisson distribution so the expected number
can be estimated from the proportion of the non-bacteraemic
mice. Then we determined the expected numbers of mice infected
with one, two or three variants, assuming that the number of
bacteria (w) responsible for establishing the blood population in
each invasion event were 1, 2, 3, etc (Table 2). Given that some
mice were culled during the course of the experiment and some
got multiple samplings, we limited the statistical analysis to the
observations at the 24 h time point. In table 2, we report the
comparison between the expected versus the observed numbers of
the infected mice with one, two and three variants for different
numbers of bacteria (w) potentially responsible for founding a
population blood. The statistical analysis shows that the most
Figure 1. Co-infection of CD1 mice with three isogenic variants of S. pneumoniae TIGR4. A mixture of three isogenic S. pneumoniae TIGR4
variants (36105 CFU/each strain) was given to CD1 mice (n = 68) by the i.v. route. Bacterial counts were performed collecting blood at various time
points. (A) Blood counts in the first 10 h after challenge. (B) Blood counts up to 72 h post-challenge, (including data reported in A). Each symbol
indicates a single mouse. Blood cultures yielding all three variants are shown in downward white triangles, those yielding two variants as upward
grey triangles, and samples yielding a monoclonal blood culture are shown as black squares. Samples from mice with negative blood cultures are
shown as open circles. The ratio of infected over un-infected mice was 0.31 at 24 h, 0.37 at 48 h and 0.67 at 72 h. The cut off for detection is 100 CFU/
ml. Data of two independent experiments are reported.
doi:10.1371/journal.ppat.1004026.g001
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probable number of bacteria responsible for establishing a blood
population is 1 (Table 2). Note that the p-value was calculated by
combining data for blood cultures with two or three variants
because of the small expected frequencies in these two categories.
Given that w is equal to one, we conclude that polyclonal blood
infections are the result of more than one invasion event, each
event founded by a single bacterium, consistent with the observed
time-dependent increase in the frequency of polyclonal bacteremia
over the 72 h of the experiment.
Depletion of macrophages and neutrophils defines the
key role of innate cellular immunity in early clearance of
bacteraemia
Prior to the assessment of the impact of host factors in the
control of bacteraemia, we compared bacterial counts in the blood
of two mouse strains known to be resistant to pneumococcal
infection (outbred CD1 mice and inbred BALB/c mice) and a
susceptible mouse strain CBA/Ca [30]. The mice were inoculated
i.v. with a mixture of three encapsulated pneumococcal strains of
different serotypes, D39 (type 2), TIGR4 (type 4) and G54 (type
19F). Bacterial clearance in CD1 and BALB/c mice showed
similar kinetics (Figure 2 A–B), while CBA/Ca mice were less able
to reduce the initial number of bacteria (Figure 2 C). All mouse
strains cleared G54 bacteria immediately (no positive blood
culture 10 min after infection) and showed a first phase of rapid
clearance also for both D39 and TIGR4. Only the two resistant
mouse strains showed bacterial numbers in the blood that were less
than the limit of detection. In contrast, bacterial numbers
increased in the susceptible strain after the first phase (Figure 2
A–C). This indicates that, depending on which host-pathogen pair
was investigated, the bottlenecks may vary considerably. Since
BALB/c mice showed a more uniform clearance of bacteria,
subsequent experiments were conducted with this mouse strain in
order to keep experimental groups to a minimal size.
To identify the host immune cells responsible for the initial
clearance of bacteria from the blood, we performed a set of
experiments in BALB/c mice depleted either of macrophages or
neutrophils. Macrophage depletion was achieved by intraperito-
neal (i.p.) injection of clodronate liposomes and neutrophil
depletion by using anti-GR-1 monoclonal antibody [31–33].
Control groups were treated either with PBS-containing liposomes
as control for clodronate experiments or with isotype-matched
antibody in the case of experiments with anti-GR-1. The results
obtained for the control groups were comparable to the untreated
control mice and differed from the groups of mice treated with
clodronate (Figure S3 A–C) or anti-GR-1 (Figure S3 E–G). To
verify macrophage or neutrophils depletion, spleen samples were
analyzed by flow cytometry. The reduction of macrophages in the
spleen of clodronate-treated mice was 61%614.2 measure by anti-
F4/80 and 47%610.4 by anti-CD11b compared to naı̈ve mice.
Similar results were obtained when liver samples were analyzed
(Figure S3 D). In anti-GR-1-treated mice, the neutrophil number
was reduced by 83%62.7 as compared to control mice (Figure S3
H). To check for anti-pneumococcal antibodies in naı̈ve mice, we
evaluated the reactivity of mouse serum towards whole pneumo-
coccal cells. Mice had no detectable serum antibodies to any of the
pneumococcal serotypes (Figure S3 I–K). A result supported by
the observation that addition of type specific rabbit serum to the
blood from naı̈ve mice conferred specific bactericidal activity (P,
0.01).
To analyse the role of macrophages and neutrophils, mice were
divided into three groups: untreated (Figure 3 A1–A4), clodronate-
treated (Figure 3 B1–B4), and anti-GR1-treated (Figure 3 C1–C4).
After i.v. challenge with a mixture of four different strains (TIGR4,
D39, DP1004 and G54), time course of bacterial counts was
monitored by sampling blood, spleen, lung, liver and kidney
(Figure 3 and S2). Analysis of control mice allowed categorisation
of the pneumococcal strains into two groups: TIGR4 and D39,
which were slowly cleared (virulent strains), and G54 and DP1004,
which were cleared from the blood within minutes. The counts of
TIGR4 and D39 were higher in the blood than in the spleen at
5 min and at 4 h compared to the other two strains (P,0.05).
Bacterial loads in the other organs were similar to those found in
the spleen (Figure S2). In contrast, mice infected with strains
DP1004 and G54 showed higher CFU counts in the spleen than in
the blood and other organs (P,0.05 at 5 min for both strains, P,
0.01 at 4 and 8 h for DP1004) (Figure 3 A3–4).
The groups of mice depleted of macrophages showed signifi-
cantly reduced ability to clear bacteria from the bloodstream. An
increase in bacterial numbers in blood from 5 min to the later time
points was observed in mice infected with TIGR4 (Figure 3 B1)
and D39 (Figure 3 B2) (P,0.01). Blood bacterial counts were
significantly higher in the clodronate-treated mice than in the
control group (P,0.05 for all time points for both D39 and
TIGR4). Bacterial counts of TIGR4 and D39 in liver and spleen
were lower but with a similar trend, over time, to those in the
blood (Figure 3 B1–B2 and Figure S2 B1–B2). In clodronate-
treated mice, the numbers of non-virulent bacteria (strains G54
and DP1004) were higher in the blood than in the spleen (P,0.05
at 5 min for DP1004 and P,0.05 at 5 and 4 h for G54) and
paralleled the trend observed for the virulent strains TIGR4 and
D39 in untreated animals (Figure 3 B3–B4 compared to A1–A2).
In neutrophil-depleted mice, bacterial counts of both TIGR4
(Figure 3 C1) and D39 (Figure 3 C2) in blood and spleen
decreased in the first 4 h after challenge with a similar trend to
that observed in untreated animals. Thereafter, blood and organ
Table 2. Statistical analysis: number of blood cultures with one, two or three pneumococcal variants observed at 24 h in the
experimental infection compared to those predicted from the statistical analysis.
total one two three
Observed infection outcome 17 12 3 2
Predicted infection outcome P
w = 1 17 14.91 1.99 0.07 0.10
w = 2 17 4.76 10.78 1.42 0.00
w = 3 17 1.57 10.03 5.37 0.00
w = 4 17 0.52 7.57 8.88 0.00
doi:10.1371/journal.ppat.1004026.t002
One-Cell Bottleneck for Invasive Infection
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counts remained stable (Figure 3 C1–C2 and Figure S2 C1–C2).
For both virulent strains, the number of bacteria were higher in
the blood than in the spleen (P,0.01 at 5 min). Interestingly,
strain G54 had a peculiar behaviour in neutrophil-depleted mice,
as it persisted in the spleen at high levels throughout the whole
experiment despite being cleared from the blood within a few min
of infection (P,0.001 at 4 and 8 h), (Figure 3 C4). At 4 h post-
infection G54 bacteria reappeared in the blood (Figure 3 C4).
The experiment was repeated for the later time points, and the
pattern of counts was identical. The rough DP1004 strain was
cleared from each body site as well as in untreated mice (Figure 3
C3).
To determine more precisely the early events occurring in the
clearance of pneumococci, we have plotted separately the data on
blood bacterial counts obtained 5 min and 30 min after challenge
(Figure 2 D–E). In untreated mice, bacterial blood counts of the
invasive strains D39 and TIGR4 were respectively 6.26104 and
5.46104 CFU/ml, while those of the non-invasive strains, DP1004
and G54, were three times lower (reduction of 60 to 75%).
Differences between the virulent and non-virulent strains were
statistically significant (P,0.01).
Spleen-derived macrophages have exceptional
phagocytic properties
Given the key role of splenic macrophages in pneumococcal
clearance, we evaluated the capacity of splenic macrophages to
internalise pneumococci. Splenic BALB/c macrophages were
grown as primary cell cultures, washed and re-cultured for seven
days in M-CSF supplemented medium. Cytoflourimetric data
showed expression of the characteristic markers of splenic
macrophages, CD11b, CD11c, F4/80 and SIGLEC-1 (Figure 2
H) [34]. Adhesion was evaluated by counting pneumococci after
45 min and phagocytosed bacteria were enumerated by plating
after a further 30 min of antibiotic treatment (viable intracellular
bacteria). Despite similar values in adherent cells (Figure 2 F), our
data show higher numbers of intracellular bacteria for the rough
DP1004 and for the G54 strain and less for the virulent D39 and
TIGR4 (Figure 2 G). Essentially identical data where obtained
when performing the experiment with splenic macrophages from
C57BL/6 mice, while in contrast bone marrow macrophages from
BALB/c mice and RAW264.7 macrophages showed different
patterns of surface markers expression to the spleen macrophages
and their phagocytosis of pneumococci showed no correlation to
Figure 2. Pneumococcal sepsis and phagocytosis by splenic macrophages. Intravenous challenge of four outbred CD1 mice (A),four inbred
BALB/c mice (B) and four inbred CBA/Ca mice (C) was performed by co-infection with D39 (red), G54 (blue) and TIGR4 (green). Bacterial counts in
blood collected at different time points from each single mouse are reported (A–C). Cut off is 100 CFU/ml). Blood counts at 5 min (D) and 30 min (E)
after i.v. infection of BALB/c mice (n = 6–12) with four pneumococcal strains: D39 (red bar), G54 (blue bar), TIGR4 (green bar) and a rough D39
derivative DP1004 (red open bar). Adhesion (F) and invasion (phagocytosis) (G) of pneumococcal strains in primary spleen macrophages from BALB/c
mice. Independent experiments were run in triplicate and reported as mean 6 SEM. Statistical analysis were performed with Kruskal-Wallis and
Dunn’s test. (H) Cytoflurimetric characterisation of surface markers of the primary spleen macrophages. A representative experiment is reported.
Comparable data on splenic macrophages isolates from C57BL/6 mice are in Figure S4.
doi:10.1371/journal.ppat.1004026.g002
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the extent of early clearance in the host (Figure S4). These data
emphasise the importance in the choice of cell lines for performing
phagocytosis assays in vitro to assess pneumococcal clearance in
vivo.
Whole genome sequencing identifies genetic evidence
for a single cell bottleneck and adaptive mutations
Pneumococci grown from the blood of 6 mice were subjected to
whole genome sequencing (Table 3). In each case, the isolates had
the identical antibiotic resistance phenotype and were therefore
presumptively monoclonal. Two of the blood cultures were
obtained from the same mouse, but at 24 or 48 h respectively,
(mouse 3.1.5; Table 3). To identify possible mutations characteris-
ing the founding cell of the monoclonal blood culture, we searched
for single nucleotide polymorphisms (SNP) present in all cells
isolated from a given blood culture. Such a SNP would
demonstrate that the re-expanded population arose from a single
cell. We identified one or two SNPs in 100% of the bacterial
populations from four out of six mice (3.1.5, 4.1.4, 4.2.2 and 4.2.6),
when compared to bacteria from the challenge inoculum (Table 3).
The identification of a SNP common to all bacteria of a given
sample is conclusive genetic evidence that the pneumococcal
populations were monoclonal. Further, the SNPs were either inter-
genic, silent or in regions not predicted to be functional in
pathogenesis. Thus, we conclude that these mutations were
unlikely to be associated with changes in within-host fitness. This
argues strongly that bacteremia was founded as the result of a
stochastic process rather than the selection of fitter variants.
However, further analysis identified a second set of SNPs in
pneumococci of 5 of 6 blood cultures. Crucially, this second set of
SNPs were only found in a proportion of the bacteria obtained
from mouse blood and therefore must have occurred after the
bottleneck. Further, these SNPs differed between isolates of
different mice, but all were located within distinct sub-units of
the pneumococcal F1/F0 ATPase operon (Table 3). In three
bloods, more than one SNP was detected. To determine if more
than one SNP in the ATPase operon occurred in a single cell, we
sequenced single colony isolates of these populations. In all cases,
where a multi-SNP profile would have been possible according to
the genomic data, only clones with a single SNP within the F1/F0
ATPase operon were recovered. These isolates included FP490, a
3.2.4 derivative with a SNP in atpA, FP487, a 3.1.5 derivative with
Figure 3. Bacterial counts in blood and spleen of BALB/c mice depleted of neutrophils or macrophages. Twelve groups of BALB/c mice
(n = 3–9) were infected by the i.v. route with four different strains of S. pneumoniae (TIGR4, D39, DP1004 and G54) at the challenge dose of
2.56105 CFU/each strain. Bacterial counts over time of each pneumococcal strain in the blood (black lines) and in the spleen (grey lines) were
reported for untreated mice (A1, A2, A3 and A4), clodronate liposomes treated mice (B1, B2, B3 and B4) and anti-GR1 mAb treated mice (C1, C2, C3
and C4). Samples were collected over 13 h, with the exception of mice treated with clodronate (8 h). The cut off is 20 CFU/ml. Data are reported as
the mean 6 SD of bacterial counts.
doi:10.1371/journal.ppat.1004026.g003
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a SNP in atpC, and FP489 and FP498, two 4.1.6 derivatives with
different SNPs in atpD (Table 1 and 3). In few cases subpopulations
with mutations in other genes were detected (pilus sortase,
potassium uptake protein, metE, and SP0760) (Table 3), but no
confirmation by direct sequencing was performed for these
genomic data and we do not think that these mutations are of
major biological relevance.
Ex vivo pneumococci with ATPase mutations show
variation in metabolic fitness
Phenotypic analysis of eight independent ex vivo blood isolates
each having a mutation (SNP) in the ATPase (Table 1 and 3),
showed normal colony morphology on agar plates and no
significant change in their susceptibility to optochin. In liquid
culture, the mutants showed normal or more efficient growth in
Todd Hewitt Yeast Extract (Figure 4 A), but were unable to grow
in other media (Tryptic Soy Broth) (Figure 4 B). Given that the
F1/F0 ATPase is involved in multiple aspects of proton trafficking,
we investigated the impact of pH, buffer composition and salt
concentration on bacterial growth. Using a phenotype microarray
for osmotic susceptibility using Biolog microtiter plates PM9, we
compared the phenotype of parental strains derived from strain
TIGR4 to the ex vivo mutants. The mutants had acquired a series
of metabolic characteristics, also shared by strain D39 (Figure S5).
Growth experiments performed in serial buffer and salt dilutions
showed that TIGR4 and its isogenic derivatives used in the
challenge experiments had a restricted pH optimum when
compared to D39, which limited growth at potassium phosphate
concentrations below 10 mM and pH below 6.8 (Figure 4 D).
Interestingly many of the mutants had gained this capacity,
making them equally able to grow at low pH as D39. In contrast,
high buffer concentrations (80 mM K2HPO4 and pH 8), inhibited
growth of all mutants (Figure 4 C).
To investigate effects on intracellular pH homeostasis of the
ATPase mutations we transformed the frame-shift in the atpC gene
into the non-encapsulated strain DP1004. Using in vivo NMR, the
Figure 4. Phenotypes of single-colony blood culture isolates. Growth profiles of wild type strains (coloured lines) and ATPase mutants (black
lines) in standard laboratory media THY (A) and TSB (B). D39 is indicated in red while TIGR4, FP318 and FP321 in different shade of green. (C, D)
Maximum OD590 reached by wild type and ATPase mutants during growth with 80 mM K2HPO4 and pH 8.0 (D) and growth at pH 6.6 (E). Kinetics of
opsono-phagocytosis assays in rotating blood with anti-type 4 serum (open symbols) and without antibodies (filled symbols) of parental strains
(green) compared to a SP1507 atpC mutant (black). (F) Phagocytosis with primary cultures of spleen macrophages of TIGR4 and FP487 atpC mutant.
(G) Bacterial counts in blood (squares) and spleen (triangles) at 72 h after i.v. infection of BALB/c mice (n = 6) with TIGR4 (green) and FP487 carrying a
frame shifted SP1507 atpC gene (black). Data points below the cut off are negative. All data were analyzed by Student’s t-test (P,0.05).
doi:10.1371/journal.ppat.1004026.g004
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atpC mutant and its parental strain were both shown to have an
identical intracellular pH of 6.52 to 6.56 during active metabolism
of glucose. No differences in susceptibility to neutrophil killing
were observed when mutants were assayed in an opsonophago-
cytosis assay in the presence of type specific antibodies (Figure 4
E). Also, data of macrophage phagocytosis were unaltered in
primary cultures of splenic macrophages (Figure 4 F). To check for
any fitness cost in vivo, the encapsulated atpC mutant was compared
to the challenge strain FP321 in our i.v. mouse sepsis model. At
early time points both strains showed comparable blood counts
(data not shown). Also at 72 h post-challenge, bacterial counts in
blood were similar, but bacterial spleen counts for the atpC mutant
were significantly increased when compared to the wild-type
(Figure 4 G).
Discussion
We have investigated the pathogenesis of pneumococcal
bacteraemia following intravenous inoculation of mice with three
isogenic clones (variants). In our model, the infection followed the
classic, three phase pattern in which a majority of pneumococci
are cleared in the first minutes post-challenge. This leads to an
‘‘eclipse phase’’ of several hours in which bacterial numbers
decline further or are undetectable. This is followed by the
emergence of sustained and high density bacteraemia in a
proportion of the challenged animals [8,10]. By analysing the
survival in the blood of three isogenic variants of S. pneumoniae, we
observed that the majority of blood cultures arose from only one of
the three variants. We used a statistical model to characterise the
infection dynamics in which the number of bacteria starting the
infection in each invasion event is w and the number of times this
happens is k [23]. From the model, we could infer that the number
of bacteria at the origin of infection is below 2 (w = 1). Thus, it
follows that bacteraemia was generated by either (a) a single
bacterium establishing a population in the blood in a single
invasion event or (b) several bacteria each of which independently
established a population in distinct invasion events. The proba-
bility of (b) is small (about 5% in our data, because the probability
of two or more invasion events occurring is about 5%). Genome
sequencing provided genetic evidence in 4/6 cases that monoclo-
nal bacteraemia did actually start from a single bacterial cell
(w = 1) confirming the first statement. For the remaining 2/6 cases
we could not determine w = 1 by genome sequencing as we could
not distinguish several invasions of a single bacterial variant from
one invasion of several cells of the same variant without any SNPs.
More complex is the experimental observation of invasive events.
For this we could document bacteraemia in mice with previous
negative blood samples (k$1) and in other mice the increase of
variants in serial blood samples (k.1). Since after the first 24 h the
observed numbers of both these types of invasion events are
similar, this strongly favours the occurrence of polyclonal
infections resulting from independent, not cooperative action. In
the case of H. influenzae it had been hypothesised that the single
cells giving rise to the monoclonal infection might be selected by
within-host evolution [23]. Our work now tests this hypothesis by
whole genome sequencing. The data show in two cases absence of
any SNPs and in four cases SNPs that apparently do not indicate
selection for virulence. Despite the low numbers, it suggests that
the single cells at the origin of infection apparently have no
advantage (higher virulence) over the other cells in the population.
Such results show that the bacteria in the challenge dose act
independently to give rise to infection, that each has a similar
probability of causing infection and that a dose near the LD50, a
single cell may initiate disease. These criteria satisfy the theory of
independent action [16,17,22,23]. As such our investigation
provides strong evidence that the single founding cell of an
invasive infection is the result of a stochastic event. However, it
must be emphasised that epigenetic variations would have eluded
our genetic and genomic analysis.
Previously published studies have shown a major role for splenic
macrophages in the initial clearance of pneumococci. In the
seminal investigations of Brown et al. [35], they conclude: ‘‘… it
appears that an anatomically normal spleen plays a unique role in
the clearance of experimental pneumococcal bacteraemia, and
that this role is of increasing importance as the pathogenicity of the
invading organism increases’’. Our data provide evidence that
splenic macrophages have properties not found in those derived
from other tissue sites, with respect to their efficiency to ingest and
kill pneumococci. It is worth noting that the impressive efficiency
of splenic clearance in vivo in the non-immune host is somewhat at
odds with the relatively inefficient ingestion and killing of
pneumococci in standard in vitro phagocytosis assays [34]. The
innate host factors that result in the removal of the vast majority of
bacteria within 45 minutes of challenge [11,35,36] deserve further
attention.
Despite the efficiency of splenic macrophages in clearance,
sustained bacteraemia eventually occurs after an eclipse phase of
several hours during which bacteria are largely undetectable in
blood. Similar data were obtained in work based on intranasal
inoculation of H. influenzae, where also mixed blood cultures were
detected in the first minutes after challenge and before the eclipse
period [25]. We propose for our intra venous injection model that
during this time, a fraction of the inoculated bacteria are
sequestered in extravascular tissues, most probably in the spleen,
in accordance with our data on positivity of bacterial spleen counts
also in mice with negative blood cultures (Figure S1). This
emergence of a clone from the potential splenic focus into the
‘‘sterile’’ bloodstream can be viewed as equivalent to the ‘‘invasive
events’’ described for models which consider more than one organ
system [16,18,21,23–25]. Sustained bacteraemia is initiated from
replication of one bacterial cell, perhaps a stochastic event in
which the first replicon to reach a threshold biomass sufficient to
seed the blood ‘‘wins the day’’. The exponential increase in the
number of bacteria in the blood is consistent with contributions
from both intravascular and extravascular replication of pneumo-
cocci. We favour a scenario in which, at a challenge dose below
the LD50, the rate of replication occurring in the extra-vascular
site, followed by seeding of bacteria to the blood, exceeds host
clearance rates thereby resulting in progressively more severe
bacteraemia. Our data do not infer that only one pneumoccocus
survives the initial host clearance, but rather that from those that
do survive; only one cell initiates bacteraemia. The observed
increase of polyclonal infections over time, as predicted also by the
independent action hypothesis, is in accordance with the doubling
of the ratio of infected mice at those time points (0.31 at 24 h to
0.67 at 72 h) [22]. The strong positive selection which drives the
emergence of the ATPase-SNP subclones during the later phase of
the infection is novel with respect to previous models (i.e. the live-
death model), which postulates a neutral selection during this
phase [16,17,37]. The in depth genomic analysis, in contrast to
previous works [16,17,37], shows evidence for a more dynamic
behaviour of the infecting bacterial population with an increase in
heterogeneity of the monoclonal population over time due to a
strong positive selection after the single cell bottleneck.
However, we observed added complexity; the residual, but
inadequate, innate clearance mechanisms exert a selective pressure
resulting in the emergence of adaptive mutants. Sequencing of
bacteria from blood revealed that in most mice the bacterial clones
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had each acquired SNPs in different sub-units of the pneumococ-
cal F1/F0 ATPase gene. This apparently high frequency of
mutations, given the relatively small biomass of pneumococci in
each animal, is consistent with the estimated mutation rates of up
to 561024 per genome described recently for pneumococci during
one-cell bottleneck in vitro passages [38]. The selection for altered
function of the ATPase, was found only in a proportion of the
bacteria making up the population obtained from blood,
compelling evidence that the ATPase mutations must have
occurred after the single cell bottleneck. As stated above, the
observation of subclones being selected during the bacteremic
phase underlines a highly dynamic situation, which extends over
the neutral two stage infection models [16,17,37].
In pneumococci, it has been recognised that ATPase mutations
occur at high frequency during pneumococcal infection in
humans, possibly in response to oxidative stress [39], and have
been described both in vitro and in clinical isolates [40–44].
Polymorphisms in F0_atpA and F0_atpC (the trans-membrane
part of the ATPase) were found to confer phenotypes of reduced
susceptibility to optochin, quinine and mefloquine [40,42,43]. In
particular, the detection of optochin resistant pneumococci in
clinical samples is well described [44], as it has a practical impact
on pneumococcal identification in the diagnostic laboratory [41].
None of the ex vivo ATPase mutants in our investigation were
optochin resistant and the SNPs accordingly did not map to the
optochin resistance conferring regions.
The F1/F0 ATPase is encoded by a highly conserved eight-gene
operon and, as in aero-tolerant anaerobes, it is involved in the
maintenance of intracellular pH through the generation of a
membrane proton gradient [45]. In some of the mutants we were
able to identify a clear metabolic benefit of the mutations which
enabled growth at pH lower than 6.8, albeit all mutants showed
that loss of capacity to grow at pH above 7.8. Interestingly the
phenotype of TIGR4 mutants recovered from blood was not
different from other virulent pneumococcal stains, such as D39.
The high frequency of mutation observed here, given by the many
different sites mutated, strongly suggests within-host adaptation
through selective pressure during sepsis. While in vitro susceptibility
of the ATPase mutants to antibody mediated neutrophil killing
and macrophage phagocytosis was essentially unaltered, the
phenotypic consequence of the ATPase mutations may be linked
to a gain in fitness related to the increased survival of bacteria
within the splenic, extravascular focus that provides the source of
pneumococci re-seeding the blood and sustaining the progressively
escalating and ultimately lethal bacteraemia. In agreement with
this hypothesis is the recent description of inhibition of the own
F1F0 ATPase by both Salmonella enterica and Mycobacterium
tuberculosis as strategy to withstand phagolysosomal activity [46].
In summary, we propose that after the majority of the bacteria
of the challenge inoculum have been removed, a few bacteria
survive the predominantly lethal activity of splenic macrophages
and neutrophils. From these rare survivors, single pneumococcal
cells may start to replicate and initiate seeding of the blood
resulting in a steady state bacteraemia in which efficient host
clearance is off-set by re-seeding from the original, persisting
extravascular reservoir of bacteria. These extravascular bacteria
are subjected to strong selection for adaptive mutations. Later
during infection, selected subpopulations of the initial clone may
become part of the bacterial population causing disease. These
observations are in accordance with a two stage model of infection
where independent action generating the initial stochastic event is
followed by a dynamic birth-death phase which increases
heterogeneity due to strong selection [16,17,24]. In the case of
the model organism S. pneumoniae, our data show different selective
pressures shaping the invasive bacterial population during
different phases of infection [16]. Given the demonstration that
pneumococci are independent in generating disease in our rodent
model and that less than twenty per cent of human pneumonia
cases are bacteraemic [3], we hypothesize that human pneumo-
coccal bacteraemia is generally monoclonal originating from a
single cell in analogy to the monoclonal meningitis case recently
described [47]. Presentation of a model which foresees develop-
ment of invasive disease from a single bacterium and strong
selection during outgrowth represents an important example on
which to model fitness selection during invasive infection.
Materials and Methods
Pneumococcal strains and growth conditions
Three isogenic zmpC knock-out mutants of TIGR4 (FP122,
FP318 and FP321) that differed only for the resistance marker,
ermB (erythromycin resistance), aad9 (spectinomycin resistance) and
aphIII (kanamycin resistance), respectively were constructed for co-
infection studies with isogenic clones [28,48]. The experiments
with mice depleted of macrophages and neutrophils were done
with four different strains: TIGR4 (serotype 4; strain FP321
zmpC::aphIII), G54 (serotype 19F; erythromycin and tetracycline
resistant) [49,50], D39 (serotype 2; strain FP335 bglA::aad9; gift of
Hasan Yesilkaya, Leicester), and the streptomycin resistant non-
encapsulated D39 derivative DP1004 [51,52]. The transfer of the
atpC frame-shift into DP1004 was performed by transformation of
a marker flanked by two PCR fragments, one of which containing
the frame-shift. This was possible since the atpC SNP is only 76 bp
from the end of the operon. Two representative transformants
FP499 and FP500 were confirmed by sequencing. The series of
ATPase mutants isolated are described in Table 3, while all other
strains are listed in Table 1. Strains were cultured in Tryptic Soy
Broth (TSB, Liophilchem, Teramo) or Todd Hewitt (THY,
Oxoid, Milano) supplemented with 0.5% Yeast Extract (Liophil-
chem). Solid media were blood agar plates (Tryptic soy agar,
Difco) supplemented with 3% horse blood (Biotech, Grosseto).
The colony morphology was checked on Todd-Hewitt agar plates
containing 200 units/ml of catalase (Sigma-Aldrich, Milano, Italy)
[53,54]. Antibiotics were used at the following concentrations:
1 mg/L erythromycin, 500 mg/L kanamycin, 100 mg/L specti-
nomycin and 500 mg/L streptomycin (all from Sigma-Aldrich).
Phenotypic assays of atpC
The intracellular pH was determined by Nuclear magnetic
resonance (NMR). In brief, 400 ml of mid log pneumococcal cells
grown in Todd Hewitt broth were pelleted and mixed with 1 ml of
sodium alginate 6% (w/v 0.9% NaCl). Mixture were extruded
manually through 25G needle on a surface of 0.25 M CaCl2
solution. The small drops were washed and transferred in the
10 mm NMR tube. NMR 31P spectra were recorded on a Bruker
DRX 600 instrument operating at 242.9 MHz. 31P spectra were
recorded with a 1.5 s repetition time and 45uflip angle. Line
broadening of 10 Hz were applied before Fourier Transform. 31P
chemical shift were determined by comparison with external
standard Trisodium trimetaphospate at 220.80 ppm. Intracellular
pH was determinate by Pi (intracellular phosphate) chemical shift
in phosphate-free perfusion model [55]. Active metabolism of
pneumococci was confirmed by acidification of the extracellular
medium during the experiment carried out at 37uC.
Growth profiles of wild type strains and ATPase mutants were
assayed both in standard laboratory media and in defined media.
Standard laboratory media included TSB (Liophilchem) and
Todd-Hewitt broth supplemented with Yeast Extract (0.5%)
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(Oxoid). Defined media were prepared in CAT medium by adding
serial concentration of potassium phosphate buffer with different
range of pH (6 to 8) and by adding several concentration of
K2HPO4 as source of salt. CAT medium was composed by:
Casitone (10gr/l) (Becton Dickinson), Tryptone (10 gr/l) (Oxoid),
Yeast Extract (1 gr/l) (Liophilchem), NaCl (5 gr/l) (Panreac,
Milano, Italy), Catalase (200 U/ml) (Sigma-Aldrich) and Glucose
(0.2%) (J.T. Baker, Milano, Italy). Metabolism of pneumococcal
strains including wild type and ATPase mutants were assayed by
Phenotype MicroArray (PM) microplate PM9 containing a total of
96 different osmolyte sources. PM technology measures active
metabolism by recording the irreversible reduction of tetrazolium
violet to formazan as an indirect evidence for NADH production.
PM procedures were carried out as previously described (Viti C
2009). Quantitative colour change were recorded automatically
every 15 min for a period of 72 h. Analyses were performed by the
Omnilog-PM Software (Biolog, inc.) and data were filtered using
average height as a parameter.
Ethics statement
Animal experimentation in Italy is regulated by Decreto
Legislativo 116/92 and Directive 210/63/EU. The animal protocol
was approved by the ‘‘Comitato Etico Locale’’ of the Azienda
Universitaria Ospedaliera Senese and received thereafter the relative
project licence issued by the Italian Ministry of Health (193/2008-B).
Mice
Six to seven-weeks old female CD1, BALB/c, and CBA/Ca
mice were purchased from Charles River Italia (Lecco, Italy). For
the bottleneck experiments, outbred CD1 mice were used, while
BALB/c mice were chosen for both in vivo macrophage and
neutrophil depletion and ex vivo experiments. CBA/Ca data are
shown only for comparison of the dynamics of the early phases of
infection. Animals were sacrificed by intraperitoneal (i.p.) injection
of xylazine hydrochloride and zolazepam tiletamine cocktail (Xilor
2%, Bio 98 S.r.l., Bologna, Italy and Zoletil 20, Virbac S.r.l.,
Milano, Italy). Mice were kept at the animal facility of the
LAMMB, University of Siena, according to its guidelines for the
maintenance of laboratory animals [48,56–58]. Blood samples
from mice were collected by sub-mandibular vein or cardiac
puncture under terminal anaesthesia. To prevent blood coagula-
tion, 100 U/ml of heparin (MS Pharma, Milano, Italy) was added.
All the collected organs (spleen, lung, liver and kidney) were
homogenized in 1 ml of TSB, and then frozen at 280uC after
making to 10% v/v of glycerol.
Challenge experiments
Two series of experiments were performed in order to define the
bottleneck for invasive pneumococcal infection with a total of 68
CD1 mice. Mice were challenged intravenously (i.v.) as described
[48,56–58] with a mixture of the three isogenic TIGR4 derivatives
(FP122, FP318 and FP321) at 3.36105 CFU each/mouse. At pre-
set time points blood samples were collected and selected groups
were sacrificed for obtainment of spleen samples. Two blood
samples from each animal, taken at different time points, are
reported in Figure 1. Bacteria were enumerated by plating on
selective media. The dose of the experiment was decided after
having observed in a preliminary experiment 5/8 mixed and 3/8
monoclonal infections using two pneumococcal clones at a dose of
2610‘6 (data not shown).
A pilot experiment for comparison of virulence in CD1, BALB/
c and CBA/Ca mice was carried out by infecting i.v. four mice
each with a mixture of G54, D39 and TIGR4 (36105 CFU each/
mouse). Three blood samples per mouse were obtained.
For depletion of macrophages, BALB/c mice were treated 24 h
prior to challenge by i.p. injection with 750 ml of a suspension of
clodronate (CL2MBP) liposomes. One control group received
PBS-containing liposomes [31] and the other was untreated.
Clodronate was encapsulated in liposomes, as described earlier
[31] and was a gift of Roche Diagnostics (Mannheim, Germany).
Neutrophil depletion was performed by a single i.p. injection of
150 mg/mouse of anti-GR-1 antibody (Ly6G and Ly6C, clone
RB8-8C5; Becton Dickinson) 24 h prior to infection [32,33]. Two
control groups were either left untreated or administered with a rat
isotype control antibody IgG2b K (kappa) (Becton Dickinson).
Groups of mice depleted of macrophages or neutrophils were
infected i.v. with 16106 CFU/mouse containing 2.56105 CFU of
each TIGR4, D39, DP1004 and G54. Bacterial viable counts were
determined at preset time points.
The virulence of the ATPase mutant FP487 (atpC mutant) was
assayed in parallel with TIGR4. BALB/c mice (n = 6) were
infected with 16106 CFU/mouse i.v. and blood and spleen
samples collected at 72 h.
Macrophage phagocytosis
Spleen and bone marrow macrophages were isolated from mice
using a modified protocol previously described [34]. Cells were
cultured in medium supplemented with 25 ng/ml of recombinant
M-CSF (Invitrogen) and re-seeded at day 7 at the concentration of
26105 cell/ml. After 24 h, 0.1 ml of pneumococci cultured to
OD590 0.25 were added. After 45 min plates were washed and
reincubated with 10 mg/L of penicillin and 200 mg/L of
gentamicin for 30 min. Intracellular bacteria were enumerated
after lysis with saponin 1%. Phagocytosis of RAW264.7 macro-
phages followed the same protocol, but in addition samples were
reincubated after removal of the antibiotics for an additional hour
in fresh medium.
Flow cytometry analysis
Flow cytometric analysis was conducted on bacteria suspended
in 1% v/v paraformaldehyde in PBS on a FACScalibur machine
(Becton Dickinson, California, USA). To verify macrophage and
neutrophil depletion, homogenised organ samples were washed in
DMEM (Sigma-Aldrich) and non-specific binding was blocked
with FcR blocking agent [59]. Cells were incubated 30 min with
1 mg of specific fluorochrome-conjugated antibodies per 106 cells.
Neutrophils were stained using a rat anti-GR-1 antibody (MACS,
Bologna, Italy). Macrophages were detected with rat anti-F4/80
mAb (BM8 clone; Abcam, Milano, Italy), and a rat anti-mouse
CD11b mAb (Becton-Dickinson). Surface markers of macrophages
were analysed using the following antibodies: anti-F4/80 mAb,
anti-mouse CD11b mAb, anti-CD11c mAb (eBioscience), anti-
mouse SIGNR1/CD209b Ab, goat IgG control Ab, anti-mouse
Siglec-1 mAb, rat IgG2A Isotype control Ab, anti-mouse
MARCO mAb and rat IgG1 isotype control Ab (R&D Systems).
To assay for the presence of anti-pneumococcal antibodies in
mouse sera, the four pneumococcal strains TIGR4, G54, D39 and
DP1004 were blocked in PBS-BSA 1% v/v for 30 min at 37uC
and incubated for 1 h at 37uC with sera (1:100) obtained from
BALB/c mice and the positive anti-serotype 2 control serum
(Staten Serum Institute, SSI, Copenhagen, DK). Samples were
marked with anti-mouse IgG (1:64) or anti-rabbit IgG (1:160;
Sigma-Aldrich).
Ex vivo blood survival assay
In order to evaluate the capacity of whole blood to kill or inhibit
the multiplication of pneumococci and to investigate the effect of
specific antibodies, ex vivo experiments were set up. Blood from
One-Cell Bottleneck for Invasive Infection
PLOS Pathogens | www.plospathogens.org 11 March 2014 | Volume 10 | Issue 3 | e1004026
BALB/c mice was collected into tubes containing heparin and
infected with pneumococci. For the assay of opsono-phagocy-
tosis of ATPase mutants 16104 CFU/ml of parental and
ATPase mutant were inoculated in blood and incubated in
rotation. The anti-type 4 serum (SSI) was used at 1:50 dilution.
For the evaluation of growth of pneumococci in blood
36105 CFU/ml of G54, D39 and TIGR4 were inoculated in
rotating blood. The efficacy of type 2 anti-serum (SSI) on D39
and its non-encapsulated derivative DP1004 was assayed as
above using a inoculum of 36105 CFU/ml and a 1:100 dilution
of the serum.
Whole genome sequencing
Chromosomal DNA was extracted using the High Pure PCR
Template preparation kit (Roche). Whole genome sequencing
was performed by the Institute of Applied Genomics and IGA
Technology Services srl (University of Udine, Italy) using an
Illumina (Solexa) Genome Analyzer II platform [60]. Reads of
both, parent and mutant strains, were aligned to the reference
genome of TIGR4 (accession NC_003028) using the Mosaik
Assembler suite (The MarthLab, Boston College, Massachu-
setts, USA). Single nucleotide polymorphisms (SNPs), inser-
tions and deletions (INDELs) were retrieved with VarScan
software [61]. SNPs and INDELs of the challenge strains were
subtracted from those found by aligning the blood isolates. All
F1/F0 ATPase mutations were re-sequenced by the Sanger
method and deposited in GenBank (accession KF705516 to
KF705525).
Statistical analysis
In order to evaluate the number of bacteria at the origin of
blood infection, a model derived from that previously described
[23], was developed. A full description of the statistical model is
given in the supplementary materials. Statistical analysis of
bacterial counts in blood and organs was performed by the
Student’s t-test for data reported in Figures 3, 4, S2 and S3. The
analysis of different bacterial blood clearance at 5 and 30 min and
the differences in bacterial phagocytosis and data of phenotype
microarray were performed using Kruskal-Wallis and Dunn’s
multiple comparison post test (Figure 2 C–F and S5). Values of P,
0.05 were considered statistically significant. The Fluorescence
Index (Figure S3 K) was calculated by multiplying the percentage
of positive events with the geometric mean fluorescence intensity
(GeoMean).
Supporting Information
Figure S1 Paired spleen and blood counts of mice from
Figure 1. Blood (black) and spleen counts (white) of single mice
(n = 12) at 24 h (A), 48 h (B) and 72 h (C) after i.v. challenge with a
mixture of three isogenic S. pneumoniae TIGR4 variants
(36105 CFU/each strain). Data are from a subset of mice shown
in Figure 1.
(PDF)
Figure S2 Bacterial counts in organs of BALB/c mice
depleted of neutrophils or macrophages (the data for
blood and spleen are those in Figure 3). A mixture of four
different pneumococcal strain (TIGR4, D39, DP1004 and G54)
were injected i.v. in BALB/c mice at the challenge dose of
2.56105 CFU/each strain (16106 CFU/mouse). Bacterial
counts in blood and organs over time are reported for untreated
mice (A1, A2, A3 and A4), clodronate liposomes treated mice
(B1, B2, B3 and B4) and anti-GR-1 mAb treated mice (C1, C2,
C3 and C4). Blood cultures are shown with red lines, while CFU
counts in the spleen, lung, liver and kidney are shown as blue,
yellow, green and pink lines respectively. All samples were
collected at different time points for 13 h, with the exception of
mice treated with clodronate (8 h). Every organ was homoge-
nized in 1 ml of medium and CFU/ml refers to counts for the
whole organ. Data are reported as the mean 6 SD of bacterial
counts (n = 3–9).
(PDF)
Figure S3 Control experiments for cell depletion in
vivo, serum antibodies and phagocytosis in BALB/c
mice. BALB/c mice were infected by the i.v. route with a mixture
of four different strains of S. pneumoniae: TIGR4 (green), D39 (fill
red circles), DP1004 (open red circles) and G54 (blue) at the
challenge dose of 2.56105 CFU/each strain (total 16106 CFU/
mouse). Bacterial blood counts at different time point are reported
for infected mice treated with clodronate liposomes (A), PBS
liposomes (B), anti-GR1 mAb (E), isotype control rat IgG2b,k (F)
and untreated mice (C and G). Data are represented as the mean
6 SD of blood bacterial counts of three mice. Macrophage
depletion (D) and neutrophil depletion (H) were confirmed by flow
cytometry analysis with specific antibodies: anti-F4/80 and anti-
CD11b for macrophage in the spleen and liver (D) and anti-GR-1
for neutrophil (H). Mean 6 SD of triplicate of independent
experiments are shown. (I) Growth of D39 (red), TIGR4 (green)
and G54 (blue) pneumococcal strains in rotated fresh blood from
BALB/c mice. A representative experiment is reported. (J) Effect
of anti-capsular serotype 2 serum (1:100) to survival of
36105 CFU/ml of D39 (red bar) and its non-encapsulated
derivative DP1004 (open bar) in mouse blood incubated for 1 h.
Mean 6 SD of three independent experiments are reported and
statistical analysis is performed by Student’s t-test. (K) Binding of
anti-type 2 specific antibody (1:100) to whole pneumococci
TIGR4 (green bar), D39 (red bar), G54 (blue bar) and rough
DP1004 (red open bar) after 1 h incubation at 37uC. No binding
was observed with non-immunized serum (1:100) from na¿ve
BALB/c mice. Data are represented as FI 6 SEM of three
independent experiments.
(PDF)
Figure S4 Phagocytosis and surface marker character-
ization of different type of macrophages. Adhesion (A) and
invasion (phagocytosis) (B) of four different pneumococcal strains
(G54, TIGR4, D39 and DP1004) in primary spleen macrophages
(SPM) isolates from C57BL/6 mice. Each symbol indicates a
single value and results are represented as mean 6 SD (n = 3). (C)
Cytofluorimetric analysis of surface markers of spleen macrophag-
es from C57BL/6 mice. A representative experiment was
reported. Invasion of different pneumococci (G54, TIGR4, D39
and DP1004) in bone marrow macrophages (BMM) isolates from
BALB/c mice (D) and in RAW264.7 macrophage cell line (F).
Data (n = 6–12) are reported as scatter plots to better evidence the
number of negative assay. Dashed lines indicate the detection
limits for positive samples. Relative analysis of surface marker
expression of bone marrow macrophages (E) and RAW264.7 (G)
by flow cytometry. Data are represented as per cent of positive
cells of representative experiments.
(PDF)
Figure S5 Phenotype MicroArray of pneumococcal
strains. Osmotic resistance of pneumococcal strains determined
by Phenotype MicroArray. Bacterial metabolic activity deter-
mined in ethylene glycol (A), sodium nitrate (B) and sodium
phosphate (C). Data were filtered using average height as a
parameter (Biolog Omnilog-PM software). TIGR4 and the two
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TIGR4 derived challenge strains are in green, D39 in red and the
mutants in black.
(PDF)
Table S1 Distribution of TIGR4 variants in monoclonal
blood cultures.
(PDF)
Text S1 Model to establish the number of invading
bacteria. Here we construct a statistical model to determine by
which of two ways bacteraemia was generated.
(PDF)
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